SCHEMBL6970332

SCHEMBL6970332

O=C1Nc2ccc(F)c(I)c2C1=Cc1ccc[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 6/20 0.60
KDR P35968 5/20 0.60
CCNE2 O96020 1/20 0.58
CCNE1 P24864 1/20 0.58
CDK2 P24941 1/20 0.58
PDGFRB P09619 5/20 0.55
NTRK1 P04629 7/20 0.55
RET P07949 4/20 0.55
FLT3 P36888 3/20 0.55
JAK3 P52333 2/20 0.55
FLT1 P17948 2/20 0.55
ALK Q9UM73 2/20 0.55
TLK2 Q86UE8 2/20 0.55
SYK P43405 1/20 0.55
ATM Q13315 1/20 0.55
CHEK1 O14757 1/20 0.55
AURKA O14965 1/20 0.55
DAPK3 O43293 1/20 0.55
PRKD3 O94806 1/20 0.55
MAP4K4 O95819 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6970326 1.00 PDPK1 (0.60) PDPK1KDRCCNE2CCNE1CDK2
SCHEMBL6967581 0.82 PDPK1 (0.72) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL6967576 0.82 PDPK1 (0.72) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL7832022 0.80 KDR (0.60) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL7832020 0.80 KDR (0.60) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL16231610 0.80 PDPK1 (0.61) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL6993762 0.78 PDPK1 (0.67) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL6993765 0.78 PDPK1 (0.67) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL6965050 0.76 PDPK1 (0.72) PDPK1KDRPDGFRBNTRK1RET
SCHEMBL6965045 0.76 PDPK1 (0.72) PDPK1KDRPDGFRBNTRK1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157019-B1 4-ALKENYL (AND ALKYNYL) OXINDOLES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES, IN PARTICULAR CDK2 HOFFMANN LA ROCHE (CH) 2003-03-19 EP disclosed
CN-1330647-A 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 HOFFMANN LA ROCHE (CH) 2002-01-09 CN disclosed
EP-1157019-A1 4-ALKENYL (AND ALKYNYL) OXINDOLES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES, IN PARTICULAR CDK2 F. HOFFMANN-LA ROCHE AG (CH) 2001-11-28 EP disclosed
EP-1149093-A1 4-ARYLOXINDOLES AS INHIBITORS OF JNK PROTEIN KINASES F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
US-6307056-B1 INHIBIT OR MODULATE PROTEIN KINASES, IN PARTICULAR JNK PROTEIN KINASES. HOFFMAN-LA ROCHE INC. 2001-10-23 US disclosed
US-6303793-B1 INTERMEDIATES FOR CYCLIN-DEPENDENT KINASE INHIBITORS HOFFMANN-LA ROCHE INC. 2001-10-16 US disclosed
US-6252086-B1 CYCLIN-DEPENDENT KINASES INHIBITORS; ANTICANCER AGENTS HOFFMANN-LA ROCHE INC. 2001-06-26 US disclosed
US-6130239-A INHIBIT CYCLIN-DEPENDENT KINASES HOFFMANN-LA ROCHE INC. (US) 2000-10-10 US disclosed
WO-2000035908-A1 4-ALKENYL (AND ALKYNYL) OXINDOLES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES, IN PARTICULAR CDK2 F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed
WO-2000035909-A1 4-ARYLOXINDOLES AS INHIBITORS OF JNK PROTEIN KINASES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed